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Abstract
The information contained within DNA is vital to directing all biological
processes. All organisms have repair mechanisms in place to repair DNA damage quickly
and efficiently. Without these repair pathways, DNA can acquire harmful mutations that
can compromise the survival of an organism. Studies of DNA repair in Drosophila
melanogaster have focused on mutagen sensitive (mus) mutants, each of which contain a
mutation that renders them incapable of performing DNA repair. Since a majority of
these mus genes are unmapped, the goal of this project was to determine what genes in
the Drosophila melanogaster genome are mus106 and mus108. Presence of each
mutation was confirmed by conducting mutagen sensitivity assays on homozygous
crosses. It was determined that the mus106 mutation is no longer present in its
corresponding stock, but that the mus108 mutation is still present in its stock. After
analyzing publically available genome data, we suggest potential candidate genes for
mus106 and mus108 to be DNA Ligase 4 and XRCC1, respectively. Since XRCC1 has not
been previously studied in Drosophila melanogaster, there are no known alleles of this
gene. However, we conducted additional mutagen sensitivity tests on a transposon and
an RNAi stock designed to target reduction of XRCC1. The results from these
experiments are inconclusive until XRCC1 knockdown is confirmed. Further
characterization of mus108 to other mutagens is in progress to better understand what
DNA repair pathway MUS108 is involved in. This work can help researchers learn more
about DNA repair pathways and fill in gaps of knowledge on gene function in D.
melanogaster.
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Research Question: What genes in the Drosophila melanogaster genome are mus106 and
mus108?
Introduction
1.1 DNA Repair
The genomes of all living things are constantly exposed to numerous substances that have
the potential to cause DNA damage. These sources of damage encompass both exogenous and
endogenous elements. Exogenous sources, also called mutagens, include ultraviolet light (UV),
ionizing radiation (IR), and environmental and chemical pollutants, while endogenous sources
result from normal metabolic processes (Hakem 2008; Torgovnick 2015). Each of these agents
creates a different type of damage which can cause problems like incorrect base pairing, single
and double stranded breaks, and formation of DNA adducts (Hakem 2008; Torgovnick 2015).
One example of a mutagen is the alkylating agent methyl methanesulfonate (MMS) which adds a
methyl group to either adenine or guanine (Beranek 1990) and results in stalled replication forks
(Lundin 2005). Damage that is left unrepaired can cause accumulation of harmful mutations that
can affect the viability of an organism. To combat this, there are numerous DNA repair pathways
that work to fix damaged DNA and maintain genomic integrity. The major eukaryotic repair
pathways are non-homologous end-joining, homologous recombination, nucleotide excision
repair, base excision repair, and single strand break repair (Hakem 2008). A deficiency in any
protein involved in these repair pathways primes cells for apoptosis or retaining mutations that
can trigger the development of cancer (Torgovnick 2015).
There are several diseases in humans that develop as a result of deficiencies in crucial
DNA repair components, such as xeroderma pigmentosum, spinocerebellar ataxia-26, and Bloom
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Syndrome (Torgovnick 2015; O’Driscoll 2012; Hoch 2017). For example, spinocerebellar ataxia
is caused by mutations in the X-ray repair cross complementing 1, known as XRCC1, gene.
XRCC1 is specifically involved in two repair pathways: base excision repair and single-strand
break repair, which are described more fully below.
The Base Excision Repair (BER) pathway is most active in the G1 phase of the cell cycle
and is responsible for fixing non-bulky lesions that result from oxidation, alkylation, and
deamination damage (Chatterjee 2017; Lee 2019). Many genes involved in this pathway are
highly conserved indicating the importance of maintaining this type of repair (Lee 2019). BER
follows three main steps to repair damaged bases: recognition, excision, and religation. Damaged
bases are recognized by a DNA glycosylase which cleaves one side of the phosphodiester bond
to create an AP (apurinic/apyrimidinic) site (Chatterjee 2017; Lee 2019). This AP site is then
recognized by AP endonuclease 1 (APE1) and breaks the bond to fully release the damaged base
(Lee 2019). The size of the repair determines if short patch or long patch repair will follow.
Short patch repair replaces a single nucleotide using polymerase beta and religates the break with
ligase 3 and XRCC1 (Chatterjee 2017; Lee 2019). Long patch repair can replace 2 to 13
nucleotides using polymerase gamma/epsilon and religates with ligase 1 and flap endonuclease
(FEN1) (Chatterjee 2017; Lee 2019).
Single strand break repair (SSBR) is closely associated with the BER pathway but there
are differences in the proteins involved. This repair pathway can be triggered by abasic sites,
oxidative damage, or problems from the topoisomerase I (TopI) enzyme (Chatterjee 2017).
Similarly to BER there are short and long patch repair pathways in SSBR. The short patch
version follows identical to that of BER where APE1 recognizes single stranded damage. Long
patch SSBR is initiated by interaction of PARP1 with the site of damage (Chatterjee 2017). The
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ends of the break are processed by APE1, polynucleotide kinase 3’-phosphate (PNKP), and
aprataxin (APTX) (Chatterjee 2017). FEN1 will then proceed to remove the 5’ end of the
damaged base, resulting in a single strand break. Polymerases will fill in the required nucleotides
and ligation is completed by ligase 1 with proliferating cell nuclear antigen (PCNA) and XRCC1
(Chatterjee 2017). Single strand breaks induced by TopI mimic the long patch version of SSBR,
but the end processing is completed by tyrosyl-DNA phosphodiesterase 1 (TDP1) to remove
TopI from the DNA break (Chatterjee 2017).

1.2 Drosophila as a model system
Scientists use model organisms to gain additional knowledge on processes like DNA
repair. The fruit fly, also known as Drosophila melanogaster, has been an important model
organism in the field of genetics. Fruit flies are incredibly useful because they are easy to
genetically modify, easy to keep in a lab setting, have short life spans, and produce numerous
offspring (Hales 2015). Many of the DNA repair pathways are conserved across a wide range of
species, and in Drosophila these repair pathways include BER, SSBR, NER and DSBR
(Sekelsky 2017). Additionally, an analysis that compared human disease genes from OMIM to
the Drosophila genome found that 77% of the human disease genes evaluated contained a
distinct D. melanogaster ortholog (Reiter 2001). For example, D. melanogaster contain a gene
for Bloom syndrome helicase that is orthologous to the Bloom helicase found in humans, making
fruit flies a great tool to further study DNA repair mechanisms (Kusano 2001).
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1.3 Mutagen Sensitivity
Researchers originally used DNA damaging agents to induce random mutations in fruit
flies to study basic genetic concepts but later focused on how the mutations formed from various
treatments (Sekelsky 2017). Thus, a series of genetic screens identified D. melanogaster mutants
that are unable to properly perform DNA repair. The screens were conducted decades ago (Boyd
1976; Boyd 1982; Gatti 1979; Oliveri 1989) however, as of 2017 only 14 of the 58 mutagensensitivity (mus) genes underlying these DNA repair defects had been identified molecularly
(Sekelsky 2017). The mutagen sensitivity genes were identified by screening for mutant flies that
exhibited sensitivity to the DNA damaging agent MMS in a mutagen-sensitivity assay (Sekelsky
2017). Briefly, a mutagen-sensitivity assay is conducted as follows: Flies with the mutation of
interest are set up in a vial to mate and lay eggs. The same adults are moved to second vial to lay
an additional round of eggs and are then discarded. Larvae are treated by exposure to either a
control substance, usually water, or the damaging agent of interest, like MMS. The control
substance and mutagen is added to the food when larvae are chewing through the food. The
larvae defective in DNA repair will experience higher amounts of cell death when exposed to the
damaging agent. The relative survival of mutagen treated flies compared to control treated flies
will determine the sensitivity of the mutation being studied. Since the initial mutagen sensitivity
screens were designed to identify as many mus genes as possible, most of the genes were only
minimally characterized beyond noting sensitivity to MMS. It is important to match each mus
line to a mutation in a particular gene to learn more about DNA repair pathways in general and
why each line expresses mutagen sensitivity.
To further our understanding of DNA repair pathways in D. melanogaster- and by
extension, the DNA repair pathways in other organisms- the work described here aimed to study
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the genes mus106 and mus108 in further detail. Both genes were selected for further study
because the FlyBase records for each gene included unpublished mapping data (Laurencon
2001), which increases the likelihood of successfully mapping the gene by narrowing the
probable gene regions. Additionally, an allele of each gene is publicly available at the
Bloomington Drosophila Stock Center, which is a repository of unique Drosophila stocks used
by researchers around the world.
The most recent reference with data on the mus106D1 and mus108A1 mutations is an
unpublished, personal communication to FlyBase from Laurencon (2001) (Thurmond 2019). The
data was part of a small-scale attempt to further map the genes using deficiency mapping. This
process involves using chromosomes that contain a deficiency, or a deleted region of genes, to
help identify the specific location of a gene of interest. The communication refers to another
publication for the treatment protocol, but it is unclear how many replicates were tested for each
condition. The communication also does not provide the raw or vial-level data for each cross and
treatment. For both mutations, Laurencon (2001) provides data on the homozygous cross in
addition to each deficiency cross at 0.08% MMS, 0.1% MMS, and a control. The data provides a
great starting point to follow up on to further map mus106D1 and mus108A1.

1.4 mus106
The mus106 gene is X-linked and represented by one recessive allele: mus106D1 (Boyd
1976; Hawley 1985; Boyd 1990). Females homozygous for the mutation are sterile (Boyd 1976;
Boyd 1982; Gatti 1979). Data collected from Boyd (1976) showed that mus106 mutants exhibit a
weak sensitivity to both MMS and gamma radiation, and do not exhibit sensitivity to nitrogen
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mustard, AAF, or UV. In addition, mus106 flies are moderately sensitive to high doses of X-ray
exposure (Oliveri 1990).
Using recombination mapping, Boyd (1976) loosely assigned mus106 to be located near
the forked gene. Later summary data roughly mapped mus106 to a region on the X chromosome
corresponding to map positions 36-44 (Gatti 1979; Smith 1980). The most recent mapping data
(unpublished) from Laurencon (2001) maps mus106 to be between the genes for up and garnet.
The mus101 gene is also located within this region, however, complementation tests between
mus101 and mus106 show they are not two alleles of the same gene (Boyd 1976; Laurencon
2001). A complementation cross is useful to determine if two mus mutations are located within
the same gene (two different alleles) or in two separate genes. This means that when mus101 and
mus106 were crossed together, flies of the mus101/mus106 genotype did not exhibit sensitivity to
a particular mutagen, meaning they complemented each other and are located in two separate
genes.

1.5 mus108
The mus108 gene is also X-linked and represented by one recessive allele: mus108A1
(Boyd 1976; Hawley 1985; Boyd 1990). Female homozygotes are sterile (Boyd 1976; Boyd
1982; Gatti 1979). mus108A1 flies are sensitive to MMS, show reduced ability for DNA synthesis
after exposure to AAF and exhibit a moderate sensitivity to high doses of X-ray exposure (Smith
1980; Oliveri 1990; Boyd 1982). Additionally, mus108 mutant flies are neither sensitive to ether
anesthesia nor gamma radiation (Gamo 1989). However, there are noticeable gaps in the
available information for mus108. For example, there is no published data describing the level of
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sensitivity that mus108 mutants exhibit when exposed to MMS. Likewise, it is unknown if
mus108 mutants are sensitive to UV or nitrogen mustard (Smith 1980; Buendia 1998), and there
is no published data on any complementation tests involving mus108.
An interesting aspect of the mus108 mutation is that it suppresses the magnification of
rDNA (rRNA-encoding genes) in male flies. This means when the number of rDNA tandem
repeats are reduced, mus108 mutants are unable to revert to wild-type levels of rDNA (Hawley
1985). These magnification events are blocked at both the pre-meiotic and meiotic stages
(Hawley 1985). This phenotype has only been recorded in mus108 mutants.
mus108 has been roughly mapped to a region on the X chromosome corresponding to the
map position 10.8 (Smith 1980). Laurencon (2001) further mapped the mutation to be within the
cytological region 4E1-4EF2.

1.6 Characterization of mus106 and mus108
In addition to mapping the location of the mus mutations, it is also important to further
characterize them to better understand their predicted role in disrupting critical DNA pathways.
Different mutagens cause different types of DNA damage, which can influence the type of repair
pathway that is triggered in a cell (Chatterjee 2017). To learn more about the repair pathways
that both mutations are involved in, we conducted a sensitivity test with two mutagens that the
mutations have not yet been tested against: hydroxyurea (HU) and camptothecin (CPT).
Hydroxyurea is a non-alkylating mutagen that has been used in treating certain cancer
types and sickle cell anemia (Singh 2016). Depending on the concentration, length of exposure,
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and cell sensitivity, exposure to HU can be cytotoxic. In general, it inhibits DNA synthesis which
results in DNA damage, stops cytokinesis and produces oxidative stress (Singh 2016).
Specifically, HU targets ribonucleotide reductase (RNR), the enzyme responsible for reducing
ribonucleoside diphosphate to deoxyribonucleotide which is required for DNA replication and
repair (Singh 2016). Cells will pause in S phase if there are not enough dNTP’s to continue
synthesizing DNA. As DNA polymerase slows down, a replication checkpoint is activated,
causing an increase in RNR production to generate more dNTP’s so that DNA synthesis can
continue (Singh 2016). However, if the replication checkpoint is not activated, then replication
forks will become unstable in the presence of HU and can collapse, cause strand breaks and
oxidative stress, and lead to cell death.
Camptothecin is an alkaloid compound used in anticancer treatments by inducing DNA
damage in rapidly dividing cancer cells (Mei 2019). CPT specifically inhibits TopI, an enzyme
that helps to relieve DNA supercoiling as replication occurs by producing single strand breaks
(SSBs) to do so. In normal circumstances, TopI will immediately release from DNA so the
strand can be religated, but in the presence of CPT, TopI is trapped on the DNA preventing the
religation step (Mei 2019). When this happens, a pathway is triggered so that TopI is degraded
and the SSB is repaired through the single strand break repair (SSBR) pathway (Mei 2019). If
the breaks are not repaired quickly enough, it can lead to the formation of double stranded breaks
(DSBs) and replication failure.
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Materials and Methods
2.1 Fly husbandry

Fly stocks were obtained from the Bloomington Drosophila Stock Center (BDSC) at
Indiana University. These stocks were: mus106D1/C(1)DX, y1 f1/Dp(1;Y)y+ (BDSC #2318);
mus108A1/C(1)DX, y1 f1 (BDSC #1490); Df(1)ED7217, w1118
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED7217/FM7h (BDSC #8952); Df(1)JC70/FM7c
(BDSC #944); Df(1)BSC823, w1118/Binsinscy (BDSC #27584); Df(1)ED6727,
w1118 P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED6727/FM7h (BDSC #8956);
w1118PBac{w[+mC]=WH}XRCC1f03685 (BDSC #18682); y1 v1; P{y[+t7.7]
v[+t1.8]=TRiP.HMJ23251}attP40 (BDSC #61359); y1 w*; P{w[+mC]=tubP-GAL4}LL7/TM3,
Sb1 Ser1 (BDSC #5138) and DGRP-59 (BDSC #28129). The FM7w stock was obtained from Jeff
Sekelsky at the University of North Carolina at Chapel Hill. Each stock is referred to using the
following abbreviations, listed in the same order as above: mus106D1, mus108A1, Df(1)ED7217,
Df(1)JC70, Df(1)BSC823, Df(1)ED6727, PBacXRCC1, TRiP, GAL4, wild-type, and FM7w.

All flies were maintained in bottles on standard corn syrup/soy food (Archon Scientific)
in a 25°C incubator on a 12-hour dark; 12-hour light cycle. For each fly cross, stocks were
placed in bottles ten days prior to virgining and cleared three to five days later to avoid
overcrowding. Kimwipes were added to the bottles as needed to absorb moisture and provide
newly-eclosed flies a solid surface to walk on. For each cross, virgin females of the appropriate
genotype were collected across four days and kept in separate vials by day. On the following
day, crosses were set up between the virgin females and males of the appropriate genotype.
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2.2 Determining Mutagen Sensitivity

To determine mutagen sensitivity, crosses were set up in bottles each containing around
20 virgin FM7w females and 15 mutagen sensitive males (mus106D1 or mus108A1) (Figure 1A).
Ten days later, virgin females of the mus106D1/FM7w or mus108A1/FM7w genotype were
collected for a total of four days. On the fifth day, crosses were set up into ten vials each with
five virgin mus/FM7w females and five of the corresponding mutagen sensitive males. The vials
were put through a mutagen sensitivity assay, which is described below:
Ten vials were set up with five females and five males for each cross, creating Brood 1
(Day zero). On Day three, the parents were flipped into new vials to create Brood 2. On Day
four, each vial of Brood 1 was treated with 250µL of ddH2O. Brood 2 vials were cleared out on
Day five and treated with 250µL of 0.08% or 0.1% MMS (Sigma) dissolved in water on Day six.
Brood 1 flies were frozen on Day 14 and Brood 2 flies frozen on Day 17. Relative survival was
calculated as the ratio of mutant to non-mutant flies in the mutagen-treated (Brood 2) vials,
normalized to the same ratio in the control (Brood 1) vials. Only vials that contained 20 or more
flies were used for relative survival calculations (as in Romero et al. 2016). A low relative
survival value indicates strong sensitivity to the mutagen. Flies were scored depending on the sex
and eye phenotype, resulting in four potential phenotypes: female with wild-type eyes, males
with wild-type eyes, females with Bar eyes, and males with Bar eyes (Figure 1B).
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A

B

Figure 1. Cross to determine mutagen sensitivity. A) Two step cross to determine mutagen
sensitivity in homozygous mus mutants. Cross applies to mus106D1 as well. B) The eye
phenotype and sex of the potential offspring that result in the mutagen sensitivity assay. Both
mus crosses result in the same phenotypes.

2.3 Deficiency Mapping
Deficiency stocks were chosen based on unpublished data from Laurencon’s (2001)
communication to FlyBase. In this communication, it was suggested that mus106 is located
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between the genes up and garnet. The deficiency Laurencon found to disrupt mus106 was
originally sought. However, there was a difference in nomenclature on FlyBase, making it
unclear which deficiency was being referred to. Upon gathering further information, it was later
determined that Df(1)g was the deficiency originally used by Laurencon (green bar in Figure 2).
In place of Df(1)g, the deficiency Df(1)ED6727 was chosen since it was smaller, covered the
undefined region found in Df(1)g, and covered the area between up and garnet (Figure 2). For
mapping mus108, one deficiency used by Laurencon (2001), Df(1)JC70, was obtained in
addition to two other stocks. Df(1)ED6727 covers the undefined portion at the beginning of
Df(1)JC70, and Df(1)BSC823 sits near the end of Df(1)JC70 covering the other undefined region
(Figure 3).
Five virgin females of deficiency stock Df(1)ED6727 were crossed to five mus106D1
males in ten vials for two separate rounds. Five virgin females of the deficiency stocks
Df(1)ED6727, Df(1)JC70, and Df(1)BSC823 were each crossed to five mus108A1 males in ten
vials each. For comparison, five wild-type/FM7w females were crossed to five wild-type males in
ten vials each. The MMS sensitivity assay was then conducted as described above in
“Determining Mutagen Sensitivity”.
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Up

Df(1)ED7217

Df(1)g

Garnet

Figure 2. Genomic location of the deficiency used for mapping mus106. Blue arrowheads represent genes of various sizes and the direction

in which they are transcribed (derived from FlyBase, Thurmond 2019). The solid red bar shows the defined region that is deleted from the

genome in the Df(1)ED7217 deficiency stock. The green bar shows the region that is deleted from the genome in the Df(1)g deficiency

stock originally used by Laurencon (2001). Dotted green lines are areas of Df(1)g that do not have a defined end point. Red circles indicate
the location of the genes up and garnet.
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Df(1)ED6727

Df(1)JC70

Df(1)BSC823

Figure 3. Genomic location of each deficiency used for mapping mus108. Blue arrowheads represent genes of various sizes and the

direction in which they are transcribed (derived from FlyBase, Thurmond 2019). The solid red bars show defined regions that are

deleted from the genome under each respective deficiency stock. Dotted red lines are areas of Df(1)JC70 that do not have a defined
end point.
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2.4 Selection of Candidate Gene for mus108
FlyBase (Thurmond 2019) was used to determine the biological functions of all
genes uncovered by Df(1)JC70 and a candidate gene was chosen from among these.

2.5 Sequencing XRCC1
DNA was extracted from a single mus108A1 male using the “Fly Squish protocol”
as in Gloor et al. 1993. Forward and reverse XRCC1 PCR primers (Table 1; Integrated
DNA Technologies) were designed using the FlyBase reference genome sequence
(Thurmond 2019) and PCR was used to amplify the candidate gene, XRCC1.
Optimization of PCR product was made by altering MgCl2 concentrations, type of
polymerase enzyme, extension time, and annealing conditions. The following conditions
produced the desired product: 1µL template DNA (derived from Fly Squish protocol
above), 0.63µL dNTP (10mM each NTP; Promega), 0.63µL 50pmol/µL primer -72,
0.63µL 50pmol/µL primer 2356a, 5µL 5x iProof (Bio-Rad) standard buffer, 0.75µL
50mM MgCl2 (final concentration: 1.5mM), 16.13µL H2O, and 0.25µL iProof (Bio-Rad)
high-fidelity DNA polymerase with an annealing temperature of 58.4°C and a one minute
and 30 second extension time.
PCR samples were then run on 0.7% agarose gel with 1x TAE buffer solution.
After optimizing PCR conditions to obtain the desired product, the DNA band was
excised from the gel, then purified using the GeneJet Gel Extraction kit (Thermo
Scientific) according to manufacturer instructions and eluted in 50µL ddH2O. The
purified DNA and primers were then sent to Eurofins Genomics for Sanger sequencing.
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Sequencing data was uploaded into the Sequencher program (Gene Codes Corporation)
to align the samples to the wild-type XRCC1 sequence on FlyBase (Thurmond 2019).
Any nucleotide differences between the reference sequence and the mus108A1 sequence
were recorded along with the amino acid encoded by those nucleotides. All observed
mutations were confirmed in a second fly prep and sequencing reaction.

Primer Name

Primer Sequence

XRCC1 -72

5’-GGCGCAACTGTCGGCAAAG-3’

XRCC1 440

5’-GCGGTGGGAGATGAATGTCG-3’

XRCC1 502

5’-GCATGTAGTGGCTGCTGCGG-3’

XRCC1 1063

5’-GCACAATTCGTCTCCAGAG-3’

XRCC1 1260a

5’-CAGATAGTCTGCACACAGCC-5’

XRCC1 1632

5’-GATTGTGACACGCAGTTGG-3’

XRCC1 2192a

5’-CGAGCATATTCGATTAAC-3’

XRCC1 2356a

5’-GCTAGAGATGGACCATCG-3’

Table 1: PCR and Sequencing Primers. Primers are numbered according to their location
with respect to the ATG of XRCC1 (-72 was 72 nucleotides before ATG). The lowercase
‘a’ refers to the antisense strand used for reverse primers. Primers -72 and 2356a were
used to isolate the full XRCC1 gene from mus108A1males. The remaining primers were
distributed throughout the coding sequence to be used for Sanger sequencing. All primers
were used for sequencing.
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2.6 XRCC1 Alignments
The following protein orthologs of XRCC1 were obtained from NCBI (National
1988): Drosophila melanogaster (accession: NP_572217) , Danio rerio (accession:
NP_0010033988), Xenopus tropicalis (accession:XP_031761618), Homo sapiens
(accession:NP_006288.2), Mus musculus (accession:NP_033558). The sequences were
aligned using default parameters in the Clustal Omega program (Sievers 2011), then
viewed using GeneDoc (Nicholas 1997).

2.7 RNAi Knockdown of XRCC1
Crosses were set up in ten vials each with five virgin TRiP females and five GAL4
males (Figure 4). The same MMS sensitivity assay was conducted as described above in
“Determining Mutagen Sensitivity”. The offspring showed the following phenotypic
combinations: wild-type bristles and wild-type wings, stubble bristles and wild-type
wings, wild-type bristles and curly wings, and stubble bristles and curly wings. Each
phenotypic combination was seen in both sexes of flies.
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Figure 4. Cross for RNAi knockdown of XRCC1. Cross between females with the RNAi
construct balanced over CurlyO (balancer for the second chromosome) to males with
GAL4 balanced over TM3, Sb, Ser (balancer for the third chromosome). +: wild-type;
CyO: CurlyO; Sb: Stubble; Ser: Serrate.

2.8 mus108 Complementation Test (with transposon in XRCC1)
One tool available for exploring XRCC1 was a piggyBac stock that contains a
transposable element located in the 5’UTR of the XRCC1 transcript (Figure 5). Crosses
were set up in bottles each containing around 20 virgin PBacXRCC1 females and 15
FM7w males (Figure 6). Ten days later, virgin females of the PBacXRCC1/FM7w
genotype were collected for a total of four days. On the fifth day, crosses were set up into
ten vials each with five virgin PBacXRCC1/FM7w females and five mus108A1 males. The
same MMS sensitivity assay was conducted as described above in “Determining Mutagen
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Sensitivity”. The offspring scored showed the same sex and phenotype combinations as
seen in Figure 1.

Figure 5. Genomic location of XRCC1 gene, XRCC1 transcript, and PBacXRCC1
element. Blue arrowhead represents the gene and the direction in which it is transcribed.
Gray regions on the left and right side of the XRCC1 transcript represent 5’ and 3’ UTRs,
respectively. Tan regions represent exons and the lines in between tan sections represent
introns. Blue triangle indicates the transgenic insertion site of the PBacXRCC1
transposon (derived from FlyBase, Thurmond 2019).
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Figure 6. Complementation cross (with transposon in XRCC1). Two step cross to
determine if mus108A1 is allelic to XRCC1.

2.9 Additional Characterization of mus108A1
To test the sensitivity of mus108A1 flies to two additional mutagens, the same
cross set up and mutagen sensitivity assay was conducted as described in “Determining
Mutagen Sensitivity” with differences in mutagens used. To test sensitivity to
hydroxyurea, Brood 2 vials were treated with 250µL of 80mM hydroxyurea (Arcos)
dissolved in water. To test sensitivity to camptothecin , a stock solution of 10mg/mL
camptothecin (Arcos) in DMSO was made and diluted into a 1% Tween-20/5% ethanol
solution to create a 50µM solution. Brood 1 vials were treated with 250µL of 1% Tween20/5% ethanol solution, and Brood 2 vials were treated with 250µL of 50µM
camptothecin.
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Results
3.1 Determining Mutagen Sensitivity
To verify the presence of a mutagen-sensitivity allele in the mus106D1 and
mus108A1 stocks, an MMS sensitivity assay was conducted on homozygous individuals
from each mus stock, and the average relative survival was calculated. Flies homozygous
for mus106D1 showed an overall relative survival of 0.94 ±0.47 when exposed to 0.08%
MMS, and an overall relative survival of 0.72 ±0.28 when exposed to 0.1% MMS (Figure
7). Flies homozygous for mus108A1 showed an overall relative survival of 0.47 ±0.25
when exposed to 0.08% MMS, and an overall relative survival of 0.26 ±0.13 when
exposed to 0.1% MMS (Figure 8). Both mutagen sensitive stocks showed a decrease in
relative survival with an increase in the MMS concentration. Overall, the mus108A1 flies
showed a lower relative survival than the mus106D1 flies.

MMS concentration
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Figure 7. Sensitivity of mus106D1 flies to MMS. Each point represents one vial. Large
horizontal line is the mean, while the upper and lower lines show standard deviation.
Graph includes two rounds of sensitivity data. Only vials with 20+ offspring were
included.

MMS concentration

Figure 8. Sensitivity of mus108A1 flies to MMS. Each point represents one vial. Large
horizontal line is the mean, while the upper and lower lines show standard deviation.
Graph includes two rounds of sensitivity data. Only vials with 20+ flies were included.

3.2 Deficiency Mapping
Crosses were conducted between the mutagen sensitivity and deficiency stocks to
narrow the location of each mus gene. Each deficiency stock contained a deletion of
varying length and location on the X chromosome. The mutagen sensitivity assay was
performed on these crosses and the relative survival calculated.
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The overall relative survival value for mus106D1/Df(1)ED7217 was 1.60 ±0.83
when exposed to 0.08% MMS (Figure 9). The overall relative survival values for
mus108A1/Df(1)ED6727 was 0.99 ±0.38, mus108A1/Df(1)JC70 was 1.00 ±0.41, and
mus108A1/Df(1)BSC823 was 0.95 ±0.53 when exposed to 0.08% MMS (Figure 10). The
relative survival values for these deficiencies were very close and have a somewhat large
standard deviation, although they are not as far spread as the mus106 deficiency data. An
ANOVA test was performed on the relative survival values of the three mus108A1
deficiencies and they were not found to be statistically different (p=0.9727). A cross of
homozygous wild-type flies was also conducted as a comparison. The average relative
survival for the wild-type cross was 0.97 ±0.17 when exposed to 0.08% MMS (Figure
10). The mus108 deficiency data was compared to the wild-type data and still presented
with no statistical difference (ANOVA; p=0.9941).

Figure 9. Sensitivity of mus106D1/Df(1)ED7217 flies to 0.08% MMS. Large horizontal
line is the mean, while the upper and lower lines show standard deviation. Graph includes

24

two rounds of sensitivity data. Each point represents one vial. Only vials with 20+
offspring were included.

Figure 10. Sensitivity of mus108A1/Df flies to 0.08% MMS. Each point represents one
vial. Large horizontal line is the mean, while the upper and lower lines show standard
deviation. Only vials with 20+ offspring were included. There was no significant
difference between the mean relative survival values of the three deficiencies (one-way
ANOVA; p=0.9727), or when compared to the wild-type cross (one-way ANOVA;
p=0.9941).

3.3 Prediction of Candidate Gene for mus108
Although the relative survival values for the three mus108A1 deficiency crosses
were similarly close to 1, previous data suggested Df(1)JC70 as a possible location for
mus108A1 (Laurencon 2001). A candidate gene was sought by investigating all genes

25

uncovered by Df(1)JC70 (Table 2). Three genes with a molecular function involved with
DNA were Klf15 (Kruppel-like Factor 15), MCM3 (Minichromosome maintenance 3)
and XRCC1 (X-ray repair cross complementing 1) which are involved in sequencespecific DNA binding, DNA replication origin binding, and damaged DNA binding,
respectively.
Symbol

Name

Molecular Function

Pp2C1

Protein phosphatase 2C

Protein serine/threonine phosphatase activity
Protein binding; Dynein light intermediate

Ctp

Cut up

chain bindings

Pyruvate dehydrogenase E1
Pdha

alpha subunit

Pyruvate dehydrogenase activity

CG7024

n/a

Dehydrogenase activity
Proctolin receptor activity; Neuropeptide

Proc-R

Proctolin receptor

receptor activity
Sequence-specific DNA binding; DNA

Klf15

Kruppel-like Factor 15

binding transcription factor activity

CG6978

n/a

Transmembrane transporter activity

CG42594

n/a

Potassium ion leak channel activity
pH-gated chloride channel activity;

CG6927

n/a

Neurotransmitter receptor activity
RNA polymerase II cis-regulatory region

CG32772

n/a

sequence specific DNA binding
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CG4041

n/a

ATP binding; GTPase activator activity
Heparan-alpha-glucosaminide N-

CG6903

n/a

acetyltransferase activity

Protein tyrosine
Ptp4E

phosphatase 4E

Protein tyrosine phosphatase activity
RNA polymerase II cis-regulatory region

Ovo

n/a

sequence specific DNA binding
RNA polymerase II cis-regulatory region

CG32767

n/a

sequence specific DNA binding
Protein kinase binding; Protein kinase A

Rg

Rugose

binding

Regulatory particle nonRpn13R

ATPase 13-related

Proteasome binding; Ubiquitin binding
Serine/threonine kinase activity; ATP

Cdk7

Cyclin-dependent kinase 7

binding
Protein of U1 & U2 snRNPs; Assemble

snf

Sans fille

spliceosome

TrxT

Thioredoxin T

Disulfide oxidoreductase activity

dhd

Deadhead

Disulfide oxidoreductase activity

Rnp4F

RNA-binding protein 4F

mRNA binding

Minichromosome
Mcm3

maintenance 3

DNA replication origin binding
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Rab guanyl-nucleotide exchange factor
CG3309

n/a

activity

XRCC1

XRCC1

Damaged DNA binding

CanB

Calcineurin B

Calcium ion binding

Small conductance
calcium-activated
SK

potassium channel

Photoreceptor activity; Calmodulin binding

Nutrient amino acid
NAAT1

transporter 1

Transmembrane transporter activity

Table 2. Abbreviated list of genes uncovered by the Df(1)JC70 deletion. All genes with
an unknown molecular function (n = 24) were removed from this abbreviated list (See
Table5 in Appendix for complete list of genes uncovered by Df(1)JC70). Genes are listed
in the same order as they appear on the D. melanogaster X chromosome (Thurmond
2019).

3.4 Sequencing XRCC1
Prior to sequencing the mus108 candidate gene XRCC1, multiple PCR reactions
were run to optimize gene amplification. Each set of reaction conditions was tested on
two primer combinations (XRCC1 -72 with XRCC1 2192a and XRCC1 -72 with XRCC1
2356a), which were predicted to produce amplicons of 2264 base pairs and 2428 base
pairs, respectively. An initial PCR reaction was run using a touchdown protocol where
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the annealing temperature decreased by 0.5°C each cycle, from 62°C to 54°C, and
2.5mM MgCl2. This reaction produced faint or non-existent bands at the predicted
amplicon sizes (data not shown). Optimization steps included using a PCR gradient to
test multiple annealing temperatures, using Taq versus iProof polymerase, and using
iProof HF versus GC buffers. Each of these conditions again produced extremely faint or
non-existent bands (data not shown). A gradient PCR using the -72 and 2356a primers
and a decreased MgCl2 concentration of 1.5mM produced a clearly defined band at an
annealing temperature of 58.4°C (Figure 11). This band was excised and purified for

60.8°C

59.9°C

58.4°C

56.9°C

55.5°C

55°C

sequencing using all of the primers listed in Table 1.

3000
1000
500

Figure 11. Isolation of XRCC1 from mus108A1 males. Representative gel from attempts
to optimize conditions for amplification of XRCC1. Lanes differ by annealing
temperature. Lane one contains the O’GeneRuler DNA Ladder Mix (Thermo Scientific).
Remaining lanes contain amplicons generated from mus108A1 males using primers -72
and 2356a using conditions as described in Materials and Methods. Black box identifies
the band excised for sequencing, ~2250 bp.
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3.5 XRCC1 Alignments
Following Sanger sequencing of the -72 and 2356a XRCC1 amplicon, the
following missense mutations between the Drosophila melanogaster reference genome
sequence and the mus108A1 sequence were identified: Q127K, Q195E, T196M, I203V,
and S204T. Four silent mutations were also found (data not shown). To assess the degree
of conservation for each of these residues, an alignment of XRCC1 protein sequences
from five species was generated as shown in Figure 12.
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Figure 12. Alignment of XRCC1 orthologs. Highlighted regions indicate the domain regions in
the human XRCC1 sequence as defined by (London 2015). Yellow= N-Terminal Domain; Blue=
Linker 1 containing a Rev1-interacting region (RIR) and a Nuclear localization signal (NLS);
Green= BRCTa domain; Pink= Linker 2 containing a phosphorylated FHA binding sequence
(PFBS); Orange= BRCTb domain. Red stars indicate missense mutations found in the mus108A1
sequences as noted in the text. Abbreviations are as follows: Dmel: Drosophila melanogaster;
Drer: Danio rerio; Xtro: Xenopus tropicalis; Hsap: Homo sapiens; Mmus: Mus musculus.

3.6 RNAi Knockdown of XRCC1
A cross between TRiP and GAL4 flies was conducted to determine if a knockdown of
XRCC1 would express a mutagen sensitive phenotype after exposure to MMS. The overall
relative survival value for the TRiP/GAL4 cross was 1.16 ±0.33 (Figure 13).
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Figure 13. Sensitivity of TRiP/GAL4 flies to 0.08% MMS. Each point represents one vial. Large
horizontal line is the mean, while the upper and lower lines show standard deviation. Only vials
with 20+ offspring were included.

3.7 mus108 Complementation Test (with transposon in XRCC1)
To determine if XRCC1 is mus108A1, a complementation cross between PBacXRCC1,
which contains a transposable element in the 5’ UTR of XRCC1, and mus108A1 was conducted.
The overall relative survival for the PBacXRCC1 cross was 0.87 ±0.29 (Figure 14). However, it
should be noted that these data were generated from only six vials (replicates) due to a lack of
PBacXRCC1/FM7 females collected during the virgining process.

Figure 14. Sensitivity of PBacXRCC1/mus108A1 flies to 0.08% MMS. Each point represents one
vial. Large horizontal line is the mean, while the upper and lower lines show standard deviation.
Only vials with 20+ offspring were included.
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Discussion
4.1 mus106
Previous research has shown that the mus106D1 mutation is recessive, located on the X
chromosome, and it is the only identified allele of mus106 (Boyd et al 1976; Hawley 1985).
mus106D1 mutants exhibit sensitivity to MMS, gamma radiation, and X-rays (Boyd et al 1976;
Oliveri 1990). The most recent data on mus106D1 was collected in 2001 in an attempt to further
narrow down the location of the mutation (Laurencon). In that study, Laurencon identified one
deficiency that failed to complement mus106D1 in MMS sensitivity assays at both 0.08% and
0.1% MMS (2001). Now, 20 years later, before further mapping efforts were made, we needed to
determine whether the mutant allele was still present in the stock by assessing sensitivity of
mus106D1 homozygotes to MMS. As shown in Figure 7, the relative survival values were 0.94
and 0.72 at 0.08% and 0.1% MMS, respectively. Even though mus106D1 is considered to have a
weak sensitivity to MMS (as compared to other mus alleles (Boyd 1976)), an average relative
survival of 0.94 at 0.08% MMS is much higher than would be expected for any “weak”
sensitivity allele and is higher than the relative survival observed for mus106D1 when it was
initially discovered (~20%) (Boyd 1976). An increase in MMS concentration however did
further reduce relative survival (Figure 7), a feature which has been observed with most mus
genes, including mus106 (Boyd 1976).
Nonetheless, the current 0.08% MMS data has a relatively large standard deviation
(±0.47), indicating many of the data points lie far from the average (Figure 7). For the 0.1%
MMS data the standard deviation was only ±0.28 (Figure 7). With such a high standard deviation
for the 0.08% MMS data, it is difficult to decide anything with certainty. It is unclear what
caused such a large value given that both rounds of the assay were conducted by the same person
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who followed the same protocol for every vial, including using the same commercially-prepared
food, same Drosophila incubator, and same methods over a two-week span.
The deficiency data for mus106D1 was also very spread out and had an average relative
survival over 1 (Figure 9). A value of 1 represents that there is no difference in the ratio of
mus106D1/Df(1)ED7217 flies to their balanced siblings between the MMS treatment and the
control. If Laurencon’s prediction is correct and mus106D1 is between the genes for up and
garnet, we would have seen much stronger sensitivity using the Df(1)ED7217 deficiency than we
did. It is possible that mus106D1 simply does not lie within the deficiency Df(1)ED7217,
considering the deficiency that Laurencon (2001) observed to disrupt mus106D1 (Df(1)g) was
much longer (606,616 bp) than Df(1)ED7217 (180,238 bp) (Figure 2). However, it would not be
expected for numerous data points in the deficiency cross to be above a relative survival of 2 or
3. Relative survival values in this range would indicate mus106D1/Df(1)ED7217 flies are
surviving in a greater ratio to their balanced siblings. This is not expected since flies with a
deficiency have a region of their genome missing and typically do not survive better than those
without such a deletion (Cook 2012). mus106D1 could be located within a different portion of the
Df(1)g deficiency. We only pursued a deficiency that covered the beginning of Df(1)g because of
the undefined start point in Df(1)g and because Df(1)ED7217 covered most of the genes between
up and garnet. To confirm if mus106D1 is located within a different part of Df(1)g, additional
deficiencies that cover the remaining portion of Df(1)g could be tested with mus106D1.
Based on the data collected on mus106, it is possible that the mus106D1 mutation is no
longer present in the stock. It has been almost 20 years since this mus allele has been worked
with (and 45 years since its original discovery) and it is possible that over time the mutation has
been lost throughout numerous generations of maintaining the stock. A loss of the mutation
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could explain why the homozygous cross and deficiency cross showed high average relative
survival values. If the mutation is no longer present then DNA damage can be repaired properly,
and the “mutant” flies would be surviving as well as their balanced siblings.
Since Laurencon narrowed down the potential location of mus106 quite specifically and
again determined that mus106 and mus101 are not alleles of the same gene, we investigated the
molecular function of genes between up and garnet to choose a potential candidate gene (Table
3) (Thurmond 2019). We propose DNA ligase 4 (DNAlig4) as a potential candidate gene for
mus106D1. Out of the genes seen in Table 3, DNAlig4 is the only gene that is involved in DNA
replication and repair, consistent with the observation that mutagen sensitivity occurs when
proteins involved in DNA repair are defective or mutated.
There is no way to confirm that the mus106D1 mutation discovered by Boyd (1976) was
an allele of DNAlig4 if the mus106D1 mutation is truly gone, since we cannot perform
complementation analysis with only one allele of mus106. However, we could do a series of
mutagen sensitivity assays with alleles of the predicted candidate gene, DNAlig4, to see if it
presents similar mutagen sensitivity to previous data seen on mus106. If so, this would further
suggest that mus106 was DNAlig4.

Symbol

Name

Molecular Function

Up

Upheld

Tropomyosin binding; calcium ion binding

Ndc80

Ndc80

Protein binding

NFAT

Nuclear factor of activated T-

DNA-binding transcription factor activity; chromatin

cells

binding activity
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DNAlig4

DNA ligase 4

DNA ligase (ATP) activity; DNA metabolism (response
to IR)

CG11164 n/a

RNA-DNA hybrid ribonuclease activity

CG15760 n/a

localize integral component of organelle membrane

CG11162 n/a

C-4 methylsterol oxidase activity

Nadsyn

NAD synthetase

NAD+ synthase activity; glutaminase activity

Nna1

Nna1 carboxypeptidase

metallocarboxypeptidase activity; zinc ion binding
activity

CG9941

n/a

ubiquitin protein ligase activity; zinc ion binding

G

Garnet

cargo adaptor activity

Table 3. Abbreviated list of genes between up and garnet. All genes with an unknown molecular
function (8) were removed from this abbreviated list (See Table 6 in Appendix for complete list
of genes between up and garnet). Genes are listed in the same order as they appear on the D.
melanogaster X chromosome (Thurmond 2019).

4.2 mus108
Previous research has shown that the mus108A1 mutation is recessive, located on the X
chromosome, and it is the only identified allele of mus108 (Boyd et al 1976; Hawley 1985).
mus108A1 mutants exhibit sensitivity to MMS, AAF, and X-rays (Smith 1980; Oliveri 1990).
Like mus106D1, the most recent data on mus108A1 was collected in 2001 in an attempt to further
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narrow down the location of the mutation (Laurencon). In Laurencon’s study, four deficiencies
failed to complement mus108A1 in an MMS sensitivity assay at both 0.08% and 0.1% (2001).
Again, it was important to determine whether the mutant allele was still present in the
stock by assessing sensitivity of mus108A1 homozygotes to MMS. mus108A1 flies exhibited a
moderate level of sensitivity when exposed to 0.08% MMS, and an increase in MMS
concentration to 0.1% further lowered relative survival. As shown in Figure 8, the relative
survival values were 0.47 and 0.26 at 0.08% and 0.1% MMS, respectively. The standard
deviation is also smaller (±0.25 at 0.08%; ±0.13 at 0.1%) than what was seen with the mus106
data, which more confidently suggests that flies homozygous for mus108A1 are still sensitive to
MMS. From the previous studies on mus108A1 there are no data that indicates what level of
sensitivity this stock should show with exposure to MMS, only that it is sensitive (Smith &
Dunsberry 1980). Although we cannot directly compare this to what was seen ~40 years ago,
mus108A1 exhibits a dose-dependent response in sensitivity, and presents a moderate level of
sensitivity based on what has been seen for other mus genes (Boyd 1976). For example,
mus101D1 is exhibits a moderate level of sensitivity with a relative survival of about 20% at
0.08% MMS (Boyd 1976).
After confirming that the mus108A1 mutation was still present in the stock, we then used
deficiency mapping to narrow the location of the gene within the fly genome. There were four
deficiency stocks that Laurencon showed to disrupt mus108A1, but only one deficiency from this
list was chosen to use in the deficiency mapping process: Df(1)JC70. The other three
deficiencies either did not have stocks available (Df(1)ovoG6 and Df(1)ovoG7) or were only
found in stocks that contained genomic deletions and duplications simultaneously (Df(1)A113).
We used Df(1)JC70 as our starting point and chose two additional deficiencies (Df(1)ED6727
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and Df(1)BSC823) that overlapped the undefined breakpoints of Df(1)JC70 to continue with the
deficiency mapping.
The rationale for our mapping assay using these deficiencies is as follows: Df(1)ED6727
deletes a section before Df(1)JC70 begins up through the undefined start point of Df(1)JC70
(Figure 3). If both Df(1)JC70 and Df(1)ED6727, for example, had shown a similar decrease in
relative survival that was significantly different from Df(1)BSC823 – i.e. a failure to complement
the mus108A1 allele – then we would have looked for a potential candidate gene within the
deleted area that Df(1)JC70 and Df(1)ED6727 overlap. Df(1)BSC823 is a smaller deficiency that
covers the undefined end region of Df(1)JC70, and the same strategy can be applied to this
deficiency and Df(1)JC70. Finally, it was possible that mus108 is located in a region that is
specific to only Df(1)JC70, in which case we would have expected to see decreased relative
survival for this deficiency only. In particular, Laurencon saw ~50% survival with this
deficiency, so we would have anticipated seeing similar values in our assay.
However, there was no significant difference in relative survival for any of the
deficiencies as compared to the wild type (ANOVA; p=0.9941) (Figure 10). The average relative
survival values for the deficiencies were 0.99, 1.00, and 0.95 for Df(1)ED6727, Df(1)JC70, and
Df(1)BSC823 respectively. This suggests that none of the deficiencies fail to complement
mus108A1 (Figure 10).
There was a large standard deviation seen in the deficiency crosses (Df(1)ED6727: ±0.38;
Df(1)JC70: ±0.41; Df(1)BSC823: ±0.53). It is possible that the large standard deviations are a
result of a modifier segregating in the stock. A modifier is a genetic variant that can modify the
overall phenotype of the primary variant or mutation. This could cause a large standard deviation
if all the X chromosomes were not identical, with the level of sensitivity changing between
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variants of the X chromosome. One way to check for this would be to restart the mus108A1 stock
from a single male, ensuring that all the X chromosomes in the stock are identical. Since we
would not know which males carry the modifier, several mus108A1 lines could be set up, each
starting from a single male. Mutagen sensitivity would be tested on each line and then compared.
If the sensitivities differ between each line, it could suggest that the stock is indeed segregating
certain sequences, whether that is mus108A1 or a modifier, which could possibly explain the large
standard deviation seen in each deficiency cross.
Another potential explanation for the lack of sensitivity seen in the deficiency crosses is
that since the mus108A1 chromosome was originally created by exposure to a mutagen, the
sensitivity we saw in the mus108A1/mus108A1 flies may be due, in part, to homozygosity for an
additional mutation(s) on the chromosome.
The data collected in this experiment does not lend support for choosing one deficiency
over another for further study. Since Laurencon originally saw that Df(1)JC70 failed to
complement mus108A1, we decided to pursue this deficiency as the target location to search for
potential candidate genes.

4.3 Proposal of a mus108 candidate gene
The relative survival of the three deficiencies used to map mus108A1 had no significant
difference in average relative survival, so we looked at the genes covered by Df(1)JC70, the
deficiency that Laurencon originally saw to uncover the mus108 mutation. Looking at the
molecular function of all the genes deleted by Df(1)JC70, we found three genes with a molecular
function involved in DNA processes (Table 2). Kruppel-like Factor 15 (Klf15) is involved in
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sequence-specific DNA binding. Minichromosome maintenance 3 (MCM3) forms part of the
MCM2-7 hexamer, which aids specifically in 3’ to 5’ DNA helicase activity and DNA
replication origin binding. X-ray repair cross complementing protein 1 (XRCC1) is involved in
damaged DNA binding. Out of these three genes, we chose XRCC1 as our candidate gene to
pursue mapping mus108 because this gene is specifically involved in repair of DNA damage,
which is a key component of the mutagen sensitive classification.

4.4 Candidate gene: XRCC1
XRCC1 is a scaffold protein that aids in the recruitment and organization of various
repair enzymes to carry out the complex processes to repair damaged DNA (London 2015/2020,
Caldecott 2019). Scaffold proteins also help reduce the chance of toxic intermediates from being
released during the repair process and causing additional damage (London 2015). The main
repair pathway XRCC1 assists in is single strand break repair (SSBR), but it also supports
interactions in the base-excision repair (BER) pathway and specific ligation issues (London
2015/2020, Caldecott 2019). Notably, alkylation damage, caused by mutagens like MMS, is
repaired by the BER pathway, making XRCC1 a stronger choice for our candidate gene (London
2015/2020).
The human XRCC1 ortholog is 633 amino acids long and contains several domains
dedicated for specific molecular interactions (Caldecott 2019). Analysis of the human ortholog
shows the domains include an N-terminal domain that binds to DNA polymerase Beta, a BRCT1
domain which binds to poly(ADP-ribose) polymerase and dsDNA, and a C-terminal domain
containing a BRCT2 domain that binds with Ligase 3 (London 2020/2015, Caldecott 2019). The
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C-terminal region is not found in Drosophila melanogaster (London 2015). There are two linker
sequences that sit between the domains. Linker 1 is ~150 amino acids long and contains a
nuclear localization signal and a Rev1-interacting region (RIR) sequence that allows Rev-1 to
bind and recruit additional polymerases (London 2015). Linker 2 is ~120 amino acids long and
contains a motif that interacts with forkhead associated (FHA) domains used to recruit additional
repair enzymes (London 2015). In humans, XRCC1 helps protect cells against damage caused by
ionizing radiation, alkylation, and UV damage (London 2015). Several mammalian cell lines
with mutations in XRCC1 have shown sensitivity to the mutagens MMS, CPT, HU, IR, and UV
radiation, and ethyl methanesulfonate (EMS) (Caldecott 2019).

4.5 Alignment of XRCC1 Orthologs
The XRCC1 gene sequence in the mus108A1 stock was compared to the reference gene
sequence on FlyBase to identify any mutations that exist in the mus108 candidate gene
(Thurmond 2019). We identified five missense mutations, shown in Figure 12 and Table 4, and
four silent mutations (data not shown). It was important to determine if any of the mutations
were located in a highly conserved region of the gene. Mutations in a highly conserved area
could be problematic to protein function because a region that is conserved across organisms
indicates importance to the functionality of that protein. The first missense mutation in the
mus108 XRCC1 sequence changes the 127th amino acid from glutamine to lysine, which is the
conserved amino acid seen in each of the orthologs examined (Figure 12, Table 4). The first
three mutations, at amino acids 127, 195, and 196, all change the chemical properties of the
amino acid (e.g. Polar/uncharged amino acid to a hydrophobic amino acid). The last two
mutations, at amino acids 203 and 204, change the amino acids, but still retain similar amino
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acid properties (i.e. Changing from one hydrophobic amino acid to a different hydrophobic
amino acid).
An alignment of XRCC1 orthologs was created to visually assess regions of conservation
in the gene. The mutation at amino acid 127 occurs in a conserved region of the N-terminal
domain of XRCC1 (Figure 12).The remaining four missense mutations are in a less conserved
region of the Linker 1 segment of the gene (Figure 12). None of the missense mutations stand out
as being potentially problematic to the XRCC1 protein. The mutation at amino acid 127 would
be promising if the amino acid were not changed to the conserved amino acid seen in the other
orthologs. Even though amino acid changes at 195 and 196 change amino acid properties, they
do not appear problematic because they are not located in a conserved region. However, it is
possible that the cluster of mutations (two sets of adjacent mutations), which are only nine amino
acids apart (195-204), could influence amino acid interactions and cause a problem with protein
structure. Of course, this is just speculation and additional research would need to be conducted
to explore this.
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Amino Acid location

Amino acid in XRCC1 reference

Amino acid in mus108 XRCC1

in Drosophila

sequence (amino acid property)

sequence (amino acid property)

127

Glutamine (polar/uncharged)

Lysine (positive charge)

195

Glutamine (polar/uncharged)

Glutamic acid (negative charge)

196

Threonine (polar/uncharged)

Methionine (hydrophobic)

203

Isoleucine (hydrophobic)

Valine (hydrophobic)

204

Serine (polar/uncharged)

Threonine (polar/uncharged)

Table 4. Missense mutations in mus108 candidate gene, XRCC1. Five missense mutations seen in
mus108 candidate gene when compared to wild-type reference sequence on FlyBase (Thurmond
2019).

4.6 RNAi Knockdown of XRCC1
An ideal experiment to determine if the candidate gene XRCC1 is mus108 would be to
conduct a complementation test between alleles of both genes. If the alleles failed to complement
each other, then that would suggest that mus108 is XRCC1. However, there are no true mutants
of XRCC1 that exist currently (Thurmond 2019) so an RNAi line designed to knockdown XRCC1
was used to determine if XRCC1 mutants are mutagen sensitive. Specifically, this RNAi line was
created as part of the Transgenic RNAi Project (TRiP) to create a genome wide collection of
RNAi stocks that can allow researchers to learn more about gene function across all tissue types
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within Drosophila (Perkins 2015). The TRiP stock chosen for this experiment contains a hairpin
that was designed to knock down XRCC1 under the control of the UAS promoter when
expressed with a GAL4 line. The goal of this cross was to establish if XRCC1 mutants present a
mutagen sensitive phenotype after exposure to MMS. Offspring that contain both the TRiP and
GAL4 genotype together should knockdown XRCC1. If a reduced relative survival is seen, it may
suggest XRCC1 is mutagen sensitive.
The data for determining if a knockdown of XRCC1 presents a mutagen sensitive
phenotype is inconclusive (Figure 13). Looking at just the average relative survival of 1.16 ±
0.33, it suggests that a knockdown of XRCC1 does not present a mutagen sensitive phenotype.
However, it is unknown if TRiP/GAL4 flies are actually knocking down XRCC1. The only way
to confirm XRCC1 knockdown is to perform a RT-qPCR and compare levels of XRCC1 in those
with TRiP/GAL4 to their siblings (those without TRiP or GAL4 or both). This is possible;
however, the mutagen is applied at the larval stage, and the phenotypic markers used in this cross
to differentiate the TRiP and GAL4 flies are seen only at the adult stage. Using the adult flies for
the RT-qPCR is possible, however this is not ideal because it is not representative of the stage
that we are assessing survival at (larval stage). Instead, two new stocks would need to be
generated that each contained a larval phenotypic marker on the appropriate chromosome
(chromosome 2 for the TRiP stock, chromosome 3 for the GAL4 stock) so that larvae with the
TRiP/GAL4 genotype can be separated from their siblings and then prepared for the RT-qPCR.
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4.7 mus108 Complementation Test (with transposon in XRCC1)
An ideal experiment to determine if XRCC1 is mus108 would be to conduct a
complementation test between alleles of the two genes. However, this is not currently possible
since there are no true mutants of XRCC1 that exist. Similarly to the RNAi lines designed as part
of TRiP, a transposon tool kit was created as another option for gene knockout in Drosophila
melanogaster (Thibault 2004). FlyBase listed an available piggyBac stock that contained a
known transposon insertion, derived from Lepidoptera, in the 5’ UTR of XRCC1 (Thibault 2004,
Thurmond 2019).
We conducted a cross between PBacXRCC1 and mus108A1 flies as a type of
complementation test to determine if XRCC1 is mus108. The average relative survival for the
PBacXRCC1 cross was 0.87 ±0.29 (Figure 14). On its own, the average relative survival suggests
PBacXRCC1/mus108A1 flies exhibit a weak sensitivity to 0.08% MMS. However, only six vials
were used for the cross due to difficulty obtaining balanced PBacXRCC1 flies from the initial
cross (Figure 6) and half of the data points lie above a relative survival value of 1, making it
difficult to conclude sensitivity.
This is a similar situation to the RNAi knockdown experiment, where it is unknown if the
piggyBac transposon is actually disrupting XRCC1. XRCC1 has not been studied in Drosophila,
and this stock was created in addition to thousands of other piggyBac stocks (Thibault 2004,
Thurmond 2019). The PBacXRCC1 stock has not been confirmed to disrupt XRCC1 gene
expression but there are a couple ways to confirm this. The first option is to perform a RT-qPCR
and compare levels of XRCC1 expression in PBacXRCC1 flies and wild-type flies. If
pBacXRCC1 disrupts gene expression, we would expect there to be a decrease in the amount of
XRCC1 RNA, meaning decreased levels of the protein, in the piggyBac flies. A second option is
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to conduct a Northern blot to compare the size of the RNA transcript in the PBacXRCC1 flies to
wild-type flies.

4.8 In progress
Additional characterization of mus108A1 to other mutagens is currently in progress. The
initial round of exposure to camptothecin and hydroxyurea failed due to the age of the food. We
are confident the age of food initially used is the reason for this setback because Brood 1 of both
assays were given older food and resulted in very few offspring. In the assay involving
hydroxyurea as the mutagen, vial ten had newer food and resulted in many offspring compared to
vial one of the same brood. Additionally, both Brood 2’s resulted in more offspring than the
corresponding Brood 1, which should not be the case. Due to time constraints the crosses have
been re-started but data collection will be completed after submission of this thesis.

4.9 Future Directions
This work has provided several options for continuing research on mus108A1. The first
suggestion for future experiments involving mus108A1 would be to restart the stock from a single
male fly to ensure that all of the X chromosomes are identical. If a modifier is segregating in the
stock there could be multiple versions of the mus108A1 X chromosome, which could be skewing
the data. Several mus108A1 lines would need to be started, each from a single male, and if
sensitivities differ between each line it could suggest that the stock is segregating certain
sequences, influencing the data obtained.
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A second suggestion for experiments using mus108A1 is to conduct complementation
analysis with other mus mutations on the X chromosome. It is assumed that previous researchers
did complete a complementation analysis to ensure that mus108A1 is not an allele of another mus
mutation, but there is no published complementation data for mus108A1. This would be a useful
step to confirm that mus108A1 represents a separate complementation group (or not).
A third suggestion is to confirm the RNAi knockdown of XRCC1 (utilizing the
GAL4/UAS system) and confirm the transposon disruption of XRCC1 (PBacXRCC1).
Confirmation of these constructs would allow future researchers to study XRCC1 in greater
detail.
A fourth suggestion for future experiments is to repeat the PBacXRCC1 transposon cross
since this project failed to acquire enough replicates for the mutagen sensitivity assay. For the
initial cross to get PBacXRCC1 balanced, more than three bottles should be set up in order to
collect enough of the PBacXRCC1/FM7 females for the second part of the cross.
Finally, future work should create mutant alleles of XRCC1 to conduct complementation
crosses to mus108A1 and measure mutagen sensitivity. If there were true alleles of XRCC1, then it
would eliminate the guess work of using non-validated RNAi or piggyBac experiments. While
this is the better option to conduct a complementation test, it is not a task that can be completed
quickly or easily, especially in the time frame for this project.

4.10 Conclusion
Even though the pandemic disrupted our initial timeline, we conducted several
experiments and reached several interesting conclusions. First, we determined that the mus106D1
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allele is no longer present in the fly stock 45 years after its initial discovery. We analyzed data
from previous researchers and utilized the publicly-available fly genome sequence to determine a
likely candidate gene for mus106D1 to be DNA ligase 4. We determined that the mus108A1
mutation is still present in the fly stock and analyzed previous research to determine a likely
candidate gene for mus108A1 to be XRCC1. While we still need to validate the disruption of
XRCC1 in the transposon and RNAi lines, we performed initial work with XRCC1, a gene that
has not been previously studied in Drosophila melanogaster.
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Appendix
Symbol

Name

Molecular Function
Protein serine/threonine phosphatase

Pp2C1

Protein phosphatase 2C

activity
Protein binding; Dynein light

Ctp

Cut up

intermediate chain bindings

Pyruvate dehydrogenase E1 alpha
Pdha

subunit

Pyruvate dehydrogenase activity

CG7024

n/a

Dehydrogenase activity
Proctolin receptor activity;

Proc-R

Proctolin receptor

Neuropeptide receptor activity

CG15472

n/a

Unknown
Sequence-specific DNA binding;
DNA binding transcription factor

Klf15

Kruppel-like Factor 15

activity

lncRNA:CR45515 Long non-coding RNA:CR45515

Unknown

CG2871

n/a

Unknown

CG15471

n/a

Unknown

CG6978

n/a

Transmembrane transporter activity

CG2861

n/a

Unknown

lncRNA:CR45516 Long non-coding RNA:CR45516

Unknown

CG12682

Unknown

n/a
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CG42594

n/a

Potassium ion leak channel activity

lncRNA:CR43495 n/a

Unknown

Boil

Unknown

Boilerman

pH-gated chloride channel activity;
CG6927

n/a

Neurotransmitter receptor activity
RNA polymerase II cis-regulatory
region sequence specific DNA

CG32772

n/a

binding
ATP binding; GTPase activator

CG4041

n/a

activity
Heparan-alpha-glucosaminide N-

CG6903

n/a

acetyltransferase activity

HpRNA:CR46342 Hairpin RNA:CR46342

Unknown

CG44774

n/a

Unknown

Ptp4E

Protein tyrosine phosphatase 4E

Protein tyrosine phosphatase activity

lncRNA:CR44833 Long non-coding RNA:CR44833

Unknown

CG15468

n/a

Unknown

lncRNA:CR45792 n/a

Unknown

CG12680

Unknown

n/a

RNA polymerase II cis-regulatory
region sequence specific DNA
Ovo

n/a

binding
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RNA polymerase II cis-regulatory
region sequence specific DNA
CG32767

n/a

binding
Protein kinase binding; Protein kinase

Rg

Rugose

A binding

CG15465

n/a

Unknown

Regulatory particle non-ATPase 13-

Proteasome binding; Ubiquitin

Rpn13R

related

binding

CG5062

n/a

Unknown

lncRNA:CR44834 n/a

Unknown

CG42749

n/a

Unknown

CG3323

n/a

Unknown

CG17764

n/a

Unknown
Serine/threonine kinase activity; ATP

Cdk7

Cyclin-dependent kinase 7

binding
Protein of U1 & U2 snRNPs;

snf

Sans fille

Assemble spliceosome

TrxT

Thioredoxin T

Disulfide oxidoreductase activity

dhd

Deadhead

Disulfide oxidoreductase activity

CG4198

n/a

Unknown

CG15930

n/a

Unknown

Sas10

Something about silencing 10

Unknown

Rnp4F

RNA-binding protein 4F

mRNA binding
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Mcm3

Minichromosome maintenance 3

3-5' DNA helicase activity
Rab guanyl-nucleotide exchange

CG3309

n/a

factor activity

XRCC1

XRCC1

Damaged DNA binding

CanB

Calcineurin B

Calcium ion binding

Small conductance calcium-activated

Photoreceptor activity; Calmodulin

SK

potassium channel

binding

NAAT1

Nutrient amino acid transporter 1

Transmembrane transporter activity

Appendix A. List of all genes uncovered by the Df(1)JC70 deletion. Genes are listed in the same
order as they appear on FlyBase (Thurmond 2019).
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Symbol

Name

Molecular Function

Up

Upheld

tropomyosin binding; calcium ion binding

lncRNA:CR44654

long non-coding

unknown

RNA:CR44654
CG11178

n/a

unknown

Ndc80

Ndc80

protein binding

tth

Toothrin

unknown

Tango2

Transport and golgi

unknown

organization 2
CG2691

n/a

unknown

NFAT

Nuclear factor of

DNA-binding transcription factor activity;

activated T-cells

chromatin binding activity; RNA polymerase
II cis-regulatory region sequence-specific
DNA binding activity

DNAlig4

DNA ligase 4

DNA ligase (ATP) activity; DNA metabolism
(response to IR)

CG11164

n/a

RNA-DNA hybrid ribonuclease activity

CG15760

n/a

localize integral component of organelle
membrane

CG11162

n/a

C-4 methylsterol oxidase activity

CG12177

n/a

unknown

CG11158

n/a

unknown

Nadsyn

NAD synthetase

NAD+ synthase activity; glutaminase activity
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Nna1

Nna1 carboxypeptidase

metallocarboxypeptidase activity; zinc ion
binding activity

CG9941

n/a

ubiquitin protein ligase activity; zinc ion
binding

mus101

mutagen-sensitive 101

unknown

G

Garnet

cargo adaptor activity

Grip91

Gamma-tubulin ring

gamma-tubulin binding; microtubule minus-

protein 91

end binding

n/a

methylthioribulose 1-phosphate dehydratase

CG11134

activity
CG11151

n/a

unknown

lncRNA:CR42861

long non-coding

unknown

RNA:CR42861
Pdcd4

Programmed cell death

unknown

4
asRNA:CR43833

antisense

unknown

RNA:CR43833
CG32625

n/a

unknown

Rtc1

Rtc1

endoribonuclease activity

Yp3

Yolk protein 3

carboxylic ester hydrolase activity

rdgB

retinal degeneration B

ion binding; lipid & phospholipid transporter
activity

CtsB

Cathepsin B

cysteine-type endopeptidase activity
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CG11103

n/a

unknown

inaE

inactivation no

lipoprotein lipase activity

afterpotential E
CG10993

n/a

RNA binding

CG10996

n/a

carbohydrate binding; aldose 1-epimerase
activity

CG11095

n/a

hydrolase activity

Clic

Chloride intracellular

glutathione peroxidase activity; chloride

channel

channel activity; lipid binding

Appendix B. List of all genes located between up and garnet. Genes are listed in the same order
as they appear on FlyBase (Thurmond 2019).

